1 unknown, 1 withdrawn. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Unknown 1, Withdrawn 1 |
Follow Hemoglobin SC Disease: new trials by email Literature Review of Hemoglobin SC Disease trials Research Report on Hemoglobin SC Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Sickle CEll Disease ComplicatioN Trial SC411, Placebo - Sickle Cell Disease | Phase 3 | Unknown | Micelle BioPharma Inc | 210 | 2019-03-01 | 2019-02-01 |
| Ketamine Sickle Cell Disease Ketamine - SC Disease, Pain, Chronic | Phase 3 | Withdrawn | University of South Florida | 2018-09-01 | 2018-09-26 |
Anemia, Sickle Cell (1) · Chronic Pain (1)
Anemia (2) · Anemia, Hemolytic (2) · Anemia, Hemolytic, Congenital (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemoglobinopathies (2) · Anemia, Sickle Cell (1) · Neurologic Manifestations (1) · Pain (1) · Pathological Conditions, Signs and Symptoms (1) · Signs and Symptoms (1)
Docosahexaenoic Acids (1) · Ketamine (1) · Soybean Oil (1)
Micelle BioPharma Inc (1) · University of South Florida (1)
Beng Fuh, MD (1) · Carton Dampier, MD (1) · Enrico Camporesi, MD (1) · Matt Heeney, MD (1)